Saltar al contenido
Merck

IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cells.

Cell reports (2014-06-03)
Serkan I Göktuna, Ozge Canli, Julia Bollrath, Alexander A Fingerle, David Horst, Michaela A Diamanti, Charles Pallangyo, Moritz Bennecke, Tim Nebelsiek, Arun K Mankan, Roland Lang, David Artis, Yinling Hu, Thomas Patzelt, Jürgen Ruland, Thomas Kirchner, M Mark Taketo, Alain Chariot, Melek C Arkan, Florian R Greten
RESUMEN

The recruitment of immune cells into solid tumors is an essential prerequisite of tumor development. Depending on the prevailing polarization profile of these infiltrating leucocytes, tumorigenesis is either promoted or blocked. Here, we identify IκB kinase α (IKKα) as a central regulator of a tumoricidal microenvironment during intestinal carcinogenesis. Mice deficient in IKKα kinase activity are largely protected from intestinal tumor development that is dependent on the enhanced recruitment of interferon γ (IFNγ)-expressing M1-like myeloid cells. In IKKα mutant mice, M1-like polarization is not controlled in a cell-autonomous manner but, rather, depends on the interplay of both IKKα mutant tumor epithelia and immune cells. Because therapies aiming at the tumor microenvironment rather than directly at the mutated cancer cell may circumvent resistance development, we suggest IKKα as a promising target for colorectal cancer (CRC) therapy.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Monoclonal Anti-Actin antibody produced in mouse, clone AC-40, ascites fluid
Sigma-Aldrich
Anti-IKKβ Antibody, clone 10AG2, clone 10AG2, Upstate®, from mouse